SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
Clinical trial NCT03448549 · UNKNOWN
Trial details
- NCT number
- NCT03448549
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2021-01-01
- Enrollment
- 1191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.